Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2012-001757-21-IT
EUCTR2012-001757-21-IT
Active, not recruiting
Phase 1

European Society of Hypertension and Chinese Hypertension League stroke in hypertension optimal treatment trial - Stroke in hypertension optimal treatment

ISTITUTO AUXOLOGICO ITALIANO0 sites7,500 target enrollmentAugust 31, 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPatients with arterial hypertension and previous stroke or transient ischemic attackMedDRA version: 15.0Level: SOCClassification code 10047065Term: Vascular disordersSystem Organ Class: 10047065 - Vascular disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Patients with arterial hypertension and previous stroke or transient ischemic attack
Sponsor
ISTITUTO AUXOLOGICO ITALIANO
Enrollment
7500
Status
Active, not recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 31, 2012
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •\- Stroke or transient ischemic attack 1 to 6 months previous to randomization; \- 65 years and above; \- Only hypertensive patients; \- Patients without statin treatment with LDL\-cholesterol \> 2\.8 mmol/l; \- Patients on statin treatment with any LDL\-cholesterol value
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range: 0
  • •F.1\.2 Adults (18\-64 years) no
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range 7500

Exclusion Criteria

  • •\- Patients in unstable clinical conditions; \- Patients with haemodynamically significant carotid stenosis or requiring carotid revascularization.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
ESH-CHL-SHOT: Blood pressure lowering and lipid lowering treatment after strokePatients with previous stroke (or transient ischaemic attack) and hypertension and hyperlipidaemia.Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2012-001757-21-SEIstituto Auxologico Italiano7,500
Completed
Phase 4
Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in HypertensivesStrokeTransient Ischemic AttackHypertension
NCT01563731Istituto Auxologico Italiano200
Withdrawn
Not Applicable
eo* Randomized Hypertension Studyrefractory high blood pressuretherapy-resistant hypertension10057166
NL-OMON37975CVRx Inc25
Recruiting
Not Applicable
Hypertension Registry of "Hypertension Prevention and Control Initiative in China"Hypertension
NCT04289701Chinese Academy of Medical Sciences, Fuwai Hospital200,000
Unknown
Not Applicable
The Chinese Early-onset Hypertension Study (CHESS)Hypertension
NCT02819674China National Center for Cardiovascular Diseases5,000